4477 |
Case #2: Hybrid Treatment with Surgery and EVT for Acute Compartment Syndrome Induced by Severe DVT |
Nai-Yu Chi |
Apr. 28. 18 |
4476 |
To Treat or Not to Treat for Gray Zone FFR(0.76-0.80) |
Seung-Jung Park |
Apr. 28. 18 |
4475 |
Case # 1: Acute Limb Case Sharing: Fight Without Weapon |
Huai-Wen Liang |
Apr. 28. 18 |
4474 |
[Case #3: TAVR in a Patient of Failing Aoritc Prosthetic Valve with AR and Paravalvular Leak] Part 3. How Did I Treat? |
Tien-Ping Tsao |
Apr. 28. 18 |
4473 |
Multivessel PCI in AMI and Cardiogenic Shock: SHOCK Trial Series Review and Real-World Application |
Davide Capodanno |
Apr. 28. 18 |
4472 |
[Case #3: TAVR in a Patient of Failing Aoritc Prosthetic Valve with AR and Paravalvular Leak] Part 2. How Would I Treat? |
Paul Toon Lim Chiam |
Apr. 28. 18 |
4471 |
Expanding Role of NOAC in PCI/AF, ACS, and Stable ASCVD: Recent Trials and Next Expectations |
David Joel Cohen |
Apr. 28. 18 |
4470 |
[Case #3: TAVR in a Patient of Failing Aoritc Prosthetic Valve with AR and Paravalvular Leak] Part 1. How Should I Treat? |
Tien-Ping Tsao |
Apr. 28. 18 |
4469 |
Why DAPT Trial Not Followed?: Moving Forward Less Duration with Smart DES, De-Escalating Strategy, and P2Y12 Inhibitor Monotherapy |
Dominick J. Angiolillo |
Apr. 28. 18 |
4468 |
[Case #2: Transcatheter Aortic Valve Implantation in a Patient with Type B Aortic Dissection] Part 3. How Did I Treat? |
Hsin-Bang Leu |
Apr. 28. 18 |